Volitionrx (VNRX) Other Non Operating Income (2021 - 2025)
Volitionrx (VNRX) posted Other Non Operating Income of -$2.2 million for Q4 2025, down 610.54% on a QoQ basis from -$308801.0 in Q3 2025, and down 12296.6% year-over-year from N/an in Q4 2024.
Volitionrx (VNRX) Other Non Operating Income (2021 - 2025) Analysis & Trends
Volitionrx's Other Non Operating Income history runs 5 years deep, the most recent figure standing at -$2.2 million for Q4 2025.
- Quarterly Other Non Operating Income fell 12296.6% year-over-year to -$2.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$2.4 million (down 3355.75% YoY) and the FY2025 annual result came in at -$1.8 million, down 1807.26% from the prior year.
- Other Non Operating Income was -$2.2 million for Q4 2025 at Volitionrx, down from -$308801.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $711730.0 in Q4 2021 and bottomed at -$2.2 million in Q4 2025.
- A 5-year average of $18963.1 and a median of $38813.5 in 2023 frame the typical range for Other Non Operating Income.
- Peak annual rise in Other Non Operating Income reached 238.93% in 2025, while the deepest fall reached 239480.62% in 2025.
- Volitionrx's Other Non Operating Income stood at $711730.0 in 2021, then dropped by 6.63% to $664546.0 in 2022, then sank by 108.9% to -$59126.0 in 2023, then jumped by 130.43% to $17990.0 in 2024, then slumped by 12296.6% to -$2.2 million in 2025.
- Business Quant data shows VNRX's Other Non Operating Income at -$2.2 million in Q4 2025, -$308801.0 in Q3 2025, and -$16263.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | Volitionrx | 89,525.10 | -1.03 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -2.19 Mn |
| Sep 30, 2025 | -308,801.00 |
| Jun 30, 2025 | -16,263.00 |
| Mar 31, 2025 | 121,566.00 |
| Dec 31, 2024 | 17,990.00 |
| Sep 30, 2024 | 129.00 |
| Mar 31, 2024 | -87,501.00 |
| Dec 31, 2023 | -59,126.00 |
| Sep 30, 2023 | 48,656.00 |
| Jun 30, 2023 | 28,971.00 |
| Dec 31, 2022 | 664,546.00 |
| Sep 30, 2022 | 171,439.00 |
| Jun 30, 2022 | 393,440.00 |
| Dec 31, 2021 | 711,730.00 |
| Sep 30, 2021 | 419,271.00 |
| Jun 30, 2021 | 391,532.00 |